Login / Signup

Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.

Giuseppina BrancaccioMassimo FasanoAdriano GrossiTeresa Antonia SantantonioGiovanni Battista Gaeta
Published in: Alimentary pharmacology & therapeutics (2019)
Patients with HDV infection and advanced liver disease maintain an increased risk of severe clinical events as compared with HBV monoinfected patients, during prolonged HBV DNA suppression with potent NA.
Keyphrases
  • hepatitis b virus
  • liver failure
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • early onset
  • circulating tumor
  • cell free
  • anti inflammatory
  • patient reported